AYTU BIOPHARMA, INC. (AYTU) Operating cash flow 2017–2026
AYTU BIOPHARMA, INC. (AYTU) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$3.3MFY2026 · since FY2017: -$13.8M → $3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $3.3M | +269.4% |
| FY2025 | -$1.9M | -39.6% |
| FY2024 | -$1.4M | +72.9% |
| FY2023 | -$5.1M | +82.2% |
| FY2022 | -$28.8M | -11.0% |
| FY2021 | -$26.0M | +8.5% |
| FY2020 | -$28.4M | -105.1% |
| FY2019 | -$13.8M | +13.2% |
| FY2018 | -$15.9M | -15.3% |
| FY2017 | -$13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AYTU financial trends
AYTU RevenueAYTU Net incomeAYTU Net marginAYTU Gross profitAYTU Gross marginAYTU Operating incomeAYTU Operating marginAYTU Free cash flowAYTU Capital expendituresAYTU Return on equityAYTU Stock buybacksAYTU Dividends paidAYTU Total assetsAYTU Total liabilitiesAYTU Shareholders’ equityAYTU overview →